Literature DB >> 8031747

Effect of mood stabilizing agents on agonist-induced calcium mobilization in human platelets.

I Kusumi1, T Koyama, I Yamashita.   

Abstract

The effect of mood stabilizing agents such as lithium, carbamazepine, valproic acid and clonazepam on serotonin(5-HT)- or thrombin-induced intracellular calcium (Ca) mobilization was studied in the platelets of healthy subjects using the fluorescent Ca indicator fura-2. After incubating platelet-rich plasma with these drugs for one or four hours, there was no significant difference in either basal Ca2+ concentration or 5-HT-stimulated Ca response between each agent treatment and control. 5-HT- or thrombin-induced Ca mobilization was not altered by four weeks of lithium carbonate administration in healthy volunteers. These results indicate that these mood stabilizers fail to affect the agonist-stimulated intracellular Ca mobilizing pathway either in vitro or ex vivo in the platelets of healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031747      PMCID: PMC1188593     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  18 in total

1.  Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders.

Authors:  I Kusumi; T Koyama; I Yamashita
Journal:  Biol Psychiatry       Date:  1992-10-15       Impact factor: 13.382

2.  Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients.

Authors:  I Kusumi; T Koyama; I Yamashita
Journal:  Biol Psychiatry       Date:  1991-08-01       Impact factor: 13.382

Review 3.  Alternative prophylactic treatments to lithium in bipolar disorders.

Authors:  M C Mauri; M Percudani; M G Regazzetti; A C Altamura
Journal:  Clin Neuropharmacol       Date:  1990       Impact factor: 1.592

4.  Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex.

Authors:  S Avissar; G Schreiber; A Danon; R H Belmaker
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

Review 5.  Clonazepam in acute and maintenance treatment of bipolar affective disorder.

Authors:  G Chouinard
Journal:  J Clin Psychiatry       Date:  1987-10       Impact factor: 4.384

6.  Effect of various factors on serotonin-induced Ca2+ response in human platelets.

Authors:  I Kusumi; T Koyama; I Yamashita
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

7.  Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.

Authors:  H Affolter; P Erne; E Bürgisser; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

Review 8.  Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium.

Authors:  R M Post; S R Weiss; D M Chuang
Journal:  J Clin Psychopharmacol       Date:  1992-02       Impact factor: 3.153

Review 9.  Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences.

Authors:  S R Nahorski; C I Ragan; R A Challiss
Journal:  Trends Pharmacol Sci       Date:  1991-08       Impact factor: 14.819

10.  Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites.

Authors:  D de Chaffoy de Courcelles; J E Leysen; F De Clerck; H Van Belle; P A Janssen
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

View more
  2 in total

1.  Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.

Authors:  Michele L Ulrich; Susan Rotzinger; Sheila J Asghar; Paul Jurasz; Veronique A Tanay; Susan M J Dunn; Marek Radomski; Andy Greenshaw; Peter H Silverstone
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

2.  Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.

Authors:  Allison C Nugent; Paul J Carlson; Earle E Bain; William Eckelman; Peter Herscovitch; Husseini Manji; Carlos A Zarate; Wayne C Drevets
Journal:  J Psychopharmacol       Date:  2013-08-07       Impact factor: 4.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.